Pulse Biosciences to Redeem Remaining 200% Warrants by July 13

Pulse Biosciences, Inc. announced its plan to deliver an irrevocable election to redeem the remaining outstanding common stock warrants (200% Warrants) issued in its July 2024 rights offering. Holders have until July 13, 2026, 5:00 p.m. ET, to exercise their warrants at $11.00 per share; unexercised warrants will be redeemed for $0.01 per share. The company met the redemption condition, with its volume weighted average price exceeding $22.00 for 20 consecutive trading days, averaging $25.17. This action is expected to generate an additional $2.1 million in gross proceeds if all remaining warrants are exercised, adding to the $60 million from the initial offering and $63.7 million from prior warrant redemptions.